EPCAM and breast cancer: Moreover, we identify a novel tumor promoting mechanism of these cells that is enhanced upon exposure to PGE2: the ability to secrete factors (such as IL-6) that are essential for the expansion of CD44+/CD24−/EpCAM+ breast cancer cells.